Download Infection, Genetics and Evolution

HIV Resistance and Sequencing Related Publications
May – July/August 2012
Journal
Title
Author
Link
AIDS
Rilpivirine Resistance Mutations in
HIV Patients Failing Non-Nucleoside
Reverse Transcriptase InhibitorBased Therapies
L. Anta, et al.
Abstract
Phylogenetic insights into HIV
transmission in North Carolina
A. M. Dennis, et al.
Abstract
E138K and M184I mutations in HIV-1
reverse transcriptase coemerge as a
result of APOBEC3 editing in the
absence of drug exposure
S. Fourati, et al.
Abstract
Baseline E138 reverse transcriptase
resistance-associated mutations in
antiretroviral-naive HIV-infected
patients
M. O. Siegel, et al.
Abstract
High rate of K65R for antiretroviral
therapy-naive patients with subtype C
HIV infection failing a tenofovircontaining first-line regimen
H. Sunpath, et al.
Abstract
Susceptibility to Etravirine of HIV Type D. Anquetil, et al.
1 Subtype C Isolates from
Nevirapine/Efavirenz-Experienced
Patients: Comparative Interpretation
of ANRS and STANFORD Algorithms
Abstract
High Rate Of Antiretroviral Drug
Resistance Mutations in HIV Type 1Infected Senegalese Children in
Virological Failure on First-Line
Treatment According to the World
Health Organization Guidelines
K. Kebe, et al.
Abstract
Prevalence of HIV-1 transmitted drug
resistance in Slovenia: 2005-2010
M. M. Lunar, et al.
Abstract
Diversity of HIV-1 and Drug
Resistance Mutations among Injecting
Drug Users in Kenya
R. Lwembe, et al.
Abstract
Transmitted antiretroviral drug
resistance in newly HIV-infected and
untreated patients in Ségou and
A. I. Maiga, et al.
Abstract
AIDS
Research and
Human
Retroviruses
Bamako Mali
Molecular Characterization of HIV
Type 1 in Brazzaville, Republic of
Congo, and First Data on Resistance
to Antiretroviral Drugs
M. Pircher, et al.
Abstract
Low Drug Resistance Levels Among
Drug-Naive Individuals with Recent
HIV Type 1 Infection in a Rural
Clinical Cohort in Southwestern
Uganda
D. Ssemwanga, et al.
Abstract
Emerging transmitted HIV drug
resistance mutations among HIV
infected patients prior to start of firstline ART in multiple sites across
China
X. Wang, et al.
Abstract
New Subtypes and Genetic
Recombination in HIV Type 1Infecting Patients with Highly Active
Antiretroviral Therapy in Peru (2008–
2010)
C. A. Yabar, et al.
Abstract
Transmitted Antiretroviral Drug
C. Yang, et al.
Resistance and Thumb Subdomain
Polymorphisms Among Newly HIV
Type 1 Diagnosed Patients Infected
with CRF01_AE and CRF07_BC Virus
in Guangdong Province, China
Abstract
HIV Type 1 Virological Response and
Prevalence of HIV Type 1 Drug
Resistance Among Patients Receiving
Antiretroviral Therapy, Shandong,
China
J. Zhang, et al.
Abstract
AIDS
Research and
Treatment
Prevalence of Drug Resistance and
Associated Mutations in a Population
of HIV-1+ Puerto Ricans: 2006–2010
A. De La Rosa, et al.
Abstract
AIDS reviews
Update on Clinical and
Methodological Recommendations for
Genotypic Determination of HIV
tropism to Guide the Usage of CCR5
Antagonists
E. Poveda, et al.
Abstract
E. L. Asahchop, et al.
Abstract
Antiviral Drug Resistance and the
Antimicrobial
Need for Development of New HIV-1
Agents and
Chemotherapy Reverse Transcriptase Inhibitors
HIV-1 tropism evolution after shortA. Gonzalez-Serna, et
term maraviroc monotherapy in HIV-1- al.
infected patients
Abstract
Mutations in HIV-1 gag and pol
Compensate for the Loss of Viral
Fitness Caused by a Highly Mutated
Protease
M. Kožíšek, et al.
Abstract
Trends in HIV-1 reverse transcriptase
resistance-associated mutations and
antiretroviral prescription data from
2003-2010
M. D. Miller, et al.
Abstract
Rilpivirine, a novel non-nucleoside
reverse transcriptase inhibitor for the
management of HIV-1 infection: a
systematic review
J. J. Schafer, et al.
Abstract
Asian Pacific
Journal of
Tropical
Medicine
Predicting a single HIV drug
resistance measure from three
international interpretation gold
standards
S. Yashik, et al.
Abstract
Biochemistry
Quantized water access to the HIV-1
protease active site as a proposed
mechanism for cooperative mutations
in drug affinity
B. A. Hall, et al.
Abstract
Biochimica et
Biophysica
Acta (BBA)Biomembrane
s
HIV-1 variants with a single-point
mutation in the gp41 pocket region
exhibiting different susceptibility to
HIV fusion inhibitors with pocket-or
membrane-binding domain
L. Lu, et al.
Abstract
Clinical
Infectious
Diseases
HIV drug resistance early warning
indicators in cohorts of individuals
starting antiretroviral therapy between
2004 and 2009: World Health
Organization global report from 50
countries
D. E. Bennett, et al.
Abstract
Transmitted HIV Drug Resistance
Among Drug-Naive Subjects Recently
Infected With HIV in Mexico City: A
World Health Organization Survey to
Classify Resistance and to Field Test
Two Alternative Patient Enrollment
Methods
S. Bertagnolio, et al.
Abstract
Antiviral
therapy
Frequent Emergence of N348I in HIV- J. H. Brehm, et al.
1 Subtype C Reverse Transcriptase
with Failure of Initial Therapy Reduces
Susceptibility to ReverseTranscriptase Inhibitors
Abstract
Experience in piloting HIV drug
resistance early warning indicators to
improve the antiretroviral program in
Abstract
E. Daoni, et al.
Papua New Guinea
Combining Cohort Analysis and
Monitoring of HIV Early-Warning
Indicators of Drug Resistance to
Assess Antiretroviral Therapy
Services in Vietnam
T. N. Do, et al.
Abstract
Surveillance of Transmitted HIV Drug
Resistance Using Matched Plasma
and Dried Blood Spot Specimens
From Voluntary Counseling and
Testing Sites in Ho Chi Minh City,
Vietnam, 2007–2008
N. B. Duc, et al.
Abstract
Monitoring of early warning indicators
for HIV drug resistance in
antiretroviral therapy clinics in
Zimbabwe
J. Dzangare, et al.
Abstract
Building Capacity for the Assessment
of HIV Drug Resistance: Experiences
From the PharmAccess African
Studies to Evaluate Resistance
Network
R. L. Hamers, et al.
Abstract
Initial Virologic Response and HIV
Drug Resistance Among HIV-Infected
Individuals Initiating First-line
Antiretroviral Therapy at 2 Clinics in
Chennai and Mumbai, India
N. K. Hingankar, et al.
Abstract
Surveillance of Transmitted HIV-1
Drug Resistance in Gauteng and
KwaZulu-Natal Provinces, South
Africa, 2005–2009
G. Hunt, et al.
Abstract
Implementing early-warning indicators
of HIV drug resistance in the
Caribbean
N. Jack, et al.
Abstract
Update on World Health Organization
HIV drug resistance prevention and
assessment strategy: 2004–2011
M. Jordan, et al.
Abstract
Are Countries Using Global Fund
Support to Implement HIV Drug
Resistance Surveillance? A Review of
Funded HIV Grants
K. F. Kelley, et al.
Abstract
Surveys of Transmitted HIV Drug
Resistance in 7 Geographic Regions
in China, 2008–2009
L. Liao, et al.
Abstract
Monitoring HIV drug resistance using
early warning indicators in China:
results from a pilot survey conducted
Y. Ma, et al.
Abstract
in 2008
HIV-1 drug resistance resulting from
antiretroviral therapy far exceeds that
from pre-exposure prophylaxis
U. M. Parikh, et al.
Abstract
Genotyping external quality assurance N. Parkin, et al.
in the World Health Organization HIV
drug resistance laboratory network
during 2007–2010
Abstract
Early Warning Indicators for
Population-Based Monitoring of HIV
Drug Resistance in 6 African
Countries
K. C. E. Sigaloff, et al.
Abstract
Virological Response and HIV Drug
Resistance 12 Months After
Antiretroviral Therapy Initiation at 2
Clinics in Nigeria
R. Ugbena, et al.
Abstract
Surveillance of HIV Drug Resistance
in Children Receiving Antiretroviral
Therapy: A Pilot Study of the World
Health Organization’s Generic
Protocol in Maputo, Mozambique
P. Vaz, et al.
Abstract
Prevalence of Transmitted HIV Drug
N. Wadonda-Kabondo,
Resistance Among Newly Diagnosed
et al.
Antiretroviral Therapy–Naive Pregnant
Women in Lilongwe and Blantyre,
Malawi
Abstract
A Retrospective Survey of HIV Drug
Resistance Among Patients 1 Year
After Initiation of Antiretroviral
Therapy at 4 Clinics in Malawi
N. Wadonda-Kabondo,
et al.
Abstract
Prediction of Treatment Failure Using
2010 World Health Organization
Guidelines Is Associated With High
Misclassification Rates and Drug
Resistance Among HIV-Infected
Cambodian Children
B. P. Westley, et al.
Abstract
Clinical
Microbiology
and Infection
Prevalence of HIV‐ 1 integrase
mutations related to resistance to
dolutegravir in raltegravir naïve and
pretreated patients
F. Saladini, et al.
Abstract
Curr Opin HIV
AIDS
CURRENT OPINION Resistance to
HIV integrase inhibitors
T. Mesplède, et al.
CURRENT OPINION HIV population
genotypic tropism testing and its
clinical significance
M. Obermeier, et al.
CURRENT OPINION Next-generation
sequencing to assess HIV tropism
L. C. Swenson, et al.
HIV Drug Resistance Interpreted by
Cumulative Versus Last Genotypes in
HIV-Infected Patients with Multiple
Treatment Failures
P. Punyacam, et al.
Abstract
Prevalence of HIV Drug Resistance
Mutation in the Northern Indian
Population After Failure of the First
Line Antiretroviral Therapy
S. Sinha, et al.
Abstract
Drugs
HIV-1 Antiretroviral resistance:
Scientific principles and clinical
applications
M. W. Tang, et al.
Abstract
Epidemics
Agent-based and phylogenetic
analyses reveal how HIV-1 moves
between risk groups: injecting drug
users sustain the heterosexual
epidemic in Latvia
F. Graw, et al.
Abstract
Future
Virology
Global analysis of sequence diversity
within HIV-1 subtypes across
geographic regions
A. Huang, et al.
Abstract
International
journal of STD
& AIDS
HIV-1 drug resistance at virological
failure versus immunological failure
among patients failing first-line
antiretroviral therapy in a resourcelimited setting
S. Sungkanuparph, et
al.
Abstract
Infection,
Genetics and
Evolution
Evidence of multiple introductions of
HIV-1 subtype C in Angola
J. M. Afonso, et al.
Abstract
J Antivir
Antiretrovir
Effect of Viral Load and Drug
Resistance on Mortality among
Chinese HIV-Infected Patients
Receiving Antiretroviral Treatment
X. Wang, et al.
Abstract
JAIDS Journal
of Acquired
Immune
Deficiency
Syndromes
Transmitted Drug Resistance and
Phylogenetic Relationships among
Acute and Early Hiv-1 Infected
Individuals in New York City
D. Castor, et al.
Abstract
AF4 HIV Drug Resistance in Nigeria,
a Cost-Effective New Methodology
P. Kanki, et al.
Abstract
N348I in HIV-1 Reverse Transcriptase
Counteracts the Synergy Between
Zidovudine and Nevirapine
T. W. Number
Abstract
The Activity of the Integrase Inhibitor
M. R. Underwood, et
Abstract
Current HIV
research
Journal of
AIDS and HIV
Research Vol
Dolutegravir Against HIV-1 Variants
Isolated From Raltegravir-Treated
Adults
al.
Prevalence of Transmitted
Antiretroviral Drug Resistance Differs
between Acutely and Chronically HIVInfected Patients
E. L. Yanik, et al.
Abstract
Genotypic diversity and mutation
profile of HIV-1 strains in antiretroviral
treatment (ART)-Naïve Ghanaian
patients and implications for
antiretroviral treatment (ART)
J. A. M. Brandful, et al.
Abstract
Increase in transmitted HIV drug
A. N. Burchell, et al.
Journal of
resistance among persons undergoing
Antimicrobial
Chemotherapy genotypic resistance testing in
Abstract
Ontario, Canada, 2002–09
Characterization of HIV-1 antiretroviral A. I. Maiga, et al.
drug resistance after second-line
treatment failure in Mali, a limitedresources setting
Abstract
Journal of
Antivirals &
Antiretrovirals
Drug Resistance Pathways and
Impact of Protease Mutation L10I/V in
HIV-1 Non-B Subtypes
L. T. Cécile
Abstract
Journal of
Biological
Chemistry
HIV-1 reverse transcriptase (RT)
polymorphism 172K, suppresses the
effect of clinically relevant drug
resistance mutations to both
nucleoside and nonnucleoside RT
inhibitors
A. Hachiya, et al.
Abstract
Journal of
Clinical
Microbiology
Continuous Spread of HIV-1 Subtypes
D and CRF01_AE in France from
2003 to 2009
D. Brand, et al.
Abstract
Journal of
Clinical
Virology
Detection of HIV-1 CXCR4 tropism
and resistance in treatment
experienced subjects receiving CCR5
antagonist—Vicriviroc
P. McNicholas, et al.
Abstract
Minority variants associated with
resistance to HIV-1 nonnucleoside
reverse transcriptase inhibitors during
primary infection
F. Nicot, et al.
Abstract
Characterization of HIV‐ 1 subtypes
and drug resistance mutations among
individuals infected with HIV in
Georgia
N. Dvali, et al.
Abstract
Journal of
Medical
Virology
Ultra-Deep Sequencing Reveals
Hidden HIV-1 Minority Lineages and
Shifts of Viral Population Between the
Main Cellular Reservoirs of the
Infection After Therapy Interruption
G. ROZERA, et al.
Abstract
Journal of
Theoretical
Biology
HIV evolution and progression of the
infection to AIDS
G. Huang, et al.
Abstract
Journal of
virological
methods
A novel denaturing heteroduplex
B. Shi, et al.
tracking assay for genotypic prediction
of HIV-1 tropism
Abstract
Journal of
Virology
Substitutions at Amino Acid Positions
143, 148, and 155 of HIV-1 Integrase
Define Distinct Genetic Barriers to
Raltegravir Resistance In Vivo
S. Fransen, et al.
Abstract
Vicriviroc Resistance Decay and
Relative Replicative Fitness in HIV-1
Clinical Isolates under Sequential
Drug Selection Pressures
A. Tsibris, et al.
Abstract
Subunit-selective mutational analysis
and tissue culture evaluations of the
interactions of the E138K and M184I
mutations in HIV-1 reverse
transcriptase
H. T. Xu, et al.
Abstract
Molecular
BioSystems
Understanding the effect of drugresistant mutations of HIV-1 intasome
on raltegravir action through
molecular modeling study
W. Xue, et al.
Abstract
Pharmacologi
cal Reviews
The Dual Role of Pharmacogenetics
in HIV Treatment: Mutations and
Polymorphisms Regulating
Antiretroviral Drug Resistance and
Disposition
V. Michaud, et al.
Abstract
Modeling HIV-1 drug resistance as
PLoS
Computational episodic directional selection
Biology
B. Murrell, et al.
Abstract
Simple Epidemiological Dynamics
Explain Phylogenetic Clustering of
HIV from Patients with Recent
Infection
E. M. Volz, et al.
Abstract
Phylogeographic Analysis of HIV-1
Subtype C Dissemination in Southern
Brazil
G. Bello, et al.
Abstract
Early Warning Indicators for HIV Drug
Resistance in Cameroon during the
S. C. Billong, et al.
Abstract
PloS one
Year 2010
HIV-1 Phenotypic Reverse
Transcriptase Inhibitor Drug
Resistance Test Interpretation Is Not
Dependent on the Subtype of the
Virus Backbone
M. Bronze, et al.
Abstract
Phylodynamics of HIV-1 Subtype C
Epidemic in East Africa
E. O. Delatorre, et al.
Abstract
Impact of low-level-viremia on HIV-1
drug-resistance evolution among
antiretroviral treated-patients
C. Delaugerre, et al.
Abstract
Low-Cost Ultra-Wide Genotyping
Using Roche/454 Pyrosequencing for
Surveillance of HIV Drug Resistance
D. M. Dudley, et al.
Abstract
Classification of HIV-1 Sequences
Using Profile Hidden Markov Models
S. K. Dwivedi, et al.
Abstract
Computational Identification of Novel
Amino-Acid Interactions in HIV Gag
via Correlated Evolution
O. V. Kalinina, et al.
Abstract
HIV-1 Subtype F1 Epidemiological
Networks among Italian Heterosexual
Males Are Associated with
Introduction Events from South
America
A. Lai, et al.
Abstract
Similar Evolution of Cellular HIV-1
DNA Level in Darunavir/Ritonavir
Monotherapy versus Triple Therapy in
MONOI–ANRS136 Trial over 96
Weeks
S. Lambert-Niclot, et al. Abstract
Relaxation of Adaptive Evolution
during the HIV-1 Infection Owing to
Reduction of CD4+ T Cell Counts
É. Leal, et al.
Abstract
Molecular Epidemiology of HIV-1
Subtypes in India: Origin and
Evolutionary History of the
Predominant Subtype C
U. Neogi, et al.
Abstract
Adaptive Evolution of HIV at HLA
Epitopes Is Associated with Ethnicity
in Canada
M. Ragonnet-Cronin, et
al.
Abstract
K65R in Subtype C HIV-1 Isolates
from Patients Failing on a First-Line
Regimen Including d4T or AZT:
Comparison of Sanger and UDP
Sequencing Data
P. Recordon-Pinson, et
al.
Abstract
Minor Protease Inhibitor Mutations at
Baseline Do Not Increase the Risk for
a Virological Failure in HIV-1 Subtype
B Infected Patients
A. U. Scherrer, et al.
Abstract
A Combined Screening Platform for
M. W. Tilghman, et al.
HIV Treatment Failure and Resistance
Abstract
The Biased Nucleotide Composition of N. Vabret, et al.
HIV-1 Triggers Type I Interferon
Response and Correlates with
Subtype D Increased Pathogenicity
Abstract
Transmitted/Founder and Chronic
Subtype C HIV-1 Use CD4 and CCR5
Receptors with Equal Efficiency and
Are Not Inhibited by Blocking the
Integrin α4β7
N. F. Parrish, et al.
Abstract
A. S. K. Braz, et al.
Abstract
Molecular epidemiology and drug
resistance prevalence of strains from
newly diagnosed HIV-1 patients in
Northern Greece during 2009-2010
Z. Antoniadou, et al.
Abstract
Molecular epidemiology of HIV-1
subtype B in the Basque Country
(Spain)
J. A. Patiño, et al.
Abstract
Frequency of subtype B and F1 dual
infection in HIV-1 positive, Brazilian
men who have sex with men
S. S. Sanabani, et al.
Abstract
Comparison of HIV-1 viral load based
on RNA or reverse transcriptase
activity in patients with suspected viral
load underestimation
B. N. Vetter, et al.
Abstract
The Lancet
Global trends in antiretroviral
resistance in treatment-naive
individuals with HIV after rollout of
antiretroviral treatment in resourcelimited settings: a global collaborative
study and meta-regression analysis
R. K. Gupta, et al.
Abstract
The Pediatric
Infectious
Disease
Journal
Prevalence of Transmitted HIV-1 Drug
Resistance Mutations in Children and
Adolescents in Sao Paulo, Brazil
F. J. Almeida, et al.
Abstract
Trends in Drug Resistance
Prevalence in HIV-1 Infected Children
M. de Mulder, et al.
Abstract
Pathogens
Relation between flexibility and
Proteins:
positively selected HIV‐ 1 protease
Structure,
Function, and mutants against inhibitors
Bioinformatics
Retrovirology
in Madrid: 1993-2010 Analysis
Viral
Immunology
Primary CXCR4 Co-receptor Use in
Acute HIV Infection Leads to Rapid
Disease Progression in the AE
Subtype
Virology
Journal
Clinical, epidemiological and
R. Alcalde, et al.
molecular features of the HIV-1
subtype C and recombinant forms that
are circulating in the city of São Paulo,
Brazil
Virus research Selected Amino Acid Changes in HIV-
Y. Jiao, et al.
Abstract
Abstract
S. Dimonte, et al.
Abstract
1 Subtype-C gp41 are Associated with
Specific gp120< sub> V3</sub>
Signatures in the Regulation of CoReceptor Usage
Viruses
Persistence versus Reversion of 3TC
Resistance in HIV-1 Determine the
Rate of Emergence of NVP
Resistance
B. A. Rath, et al.
Abstract
World Journal
of AIDS
Genetic Diversity and Antiretroviral
Drug Resistance among Drug-Naïve
HIV-1 Infected Pregnant Women
Attending Antenatal Clinics in Abidjan,
Côte d’Ivoire
L. Y. Guillaume, et al.
Abstract